Amod A. Sarnaik

Moffitt Cancer Center

Papers

2

Total Citations

22

H-Index

2

About

Amod A. Sarnaik is a leading surgical oncologist whose research focuses on advanced surgical techniques for melanoma, particularly the role of robotic-assisted pelvic lymphadenectomy. His major contributions have redefined the surgical management of metastatic melanoma, demonstrating that minimally invasive approaches can achieve durable oncologic outcomes comparable to traditional open surgery. In his landmark 2016 study, he compared robotic-assisted transperitoneal pelvic lymphadenectomy to open procedures, showing that robotic techniques reduce morbidity while maintaining oncologic integrity. His 2019 follow-up study, with 8 citations, confirmed that these robotic procedures result in lasting survival benefits for select patients with iliac or obturator nodal involvement. Sarnaik’s work has been instrumental in establishing robotic surgery as a viable, less invasive alternative for melanoma patients who require pelvic lymphadenectomy, challenging the historical controversy surrounding the procedure. His research has directly influenced clinical guidelines and expanded surgical options, improving recovery times and quality of life for patients with advanced melanoma. Through these contributions, Sarnaik has positioned himself as a key figure in the evolution of melanoma surgery, bridging the gap between technological innovation and patient-centered oncologic care.

Research Focus

Key Achievements

2
H-Index
2
Papers
22
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-Assisted Transperitoneal Pelvic Lymphadenectomy for Metastatic Melanoma: Early Outcomes Compared with Open Pelvic Lymphadenectomy
14 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Moffitt Cancer Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago